Literature DB >> 30547438

Network-Based Drug Repositioning: Approaches, Resources, and Research Directions.

Salvatore Alaimo1, Alfredo Pulvirenti2.   

Abstract

The wealth of knowledge and omic data available in drug research allowed the rising of several computational methods in drug discovery field yielding a novel and exciting application called drug repositioning. Several computational methods try to make a high-level integration of all the knowledge in order to discover unknown mechanisms. In this chapter we present an in-depth review of data resources and computational models for drug repositioning.

Keywords:  Drug repositioning; Drug-target interaction prediction; Interaction networks; Network-based drug repurposing; Precision medicine

Mesh:

Substances:

Year:  2019        PMID: 30547438     DOI: 10.1007/978-1-4939-8955-3_6

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  12 in total

1.  Using informative features in machine learning based method for COVID-19 drug repurposing.

Authors:  Rosa Aghdam; Mahnaz Habibi; Golnaz Taheri
Journal:  J Cheminform       Date:  2021-09-20       Impact factor: 5.514

2.  Folic acid: a potential inhibitor against SARS-CoV-2 nucleocapsid protein.

Authors:  Yu-Meng Chen; Jin-Lai Wei; Rui-Si Qin; Jin-Ping Hou; Guang-Chao Zang; Guang-Yuan Zhang; Ting-Ting Chen
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

3.  Structure-based drug repurposing against COVID-19 and emerging infectious diseases: methods, resources and discoveries.

Authors:  Yosef Masoudi-Sobhanzadeh; Aysan Salemi; Mohammad M Pourseif; Behzad Jafari; Yadollah Omidi; Ali Masoudi-Nejad
Journal:  Brief Bioinform       Date:  2021-11-05       Impact factor: 11.622

4.  Transcriptome-Guided Drug Repositioning.

Authors:  Arsen Arakelyan; Lilit Nersisyan; Maria Nikoghosyan; Siras Hakobyan; Arman Simonyan; Lydia Hopp; Henry Loeffler-Wirth; Hans Binder
Journal:  Pharmaceutics       Date:  2019-12-12       Impact factor: 6.321

5.  Integrative Genomic-Epigenomic Analysis of Clozapine-Treated Patients with Refractory Psychosis.

Authors:  Yerye Gibrán Mayén-Lobo; José Jaime Martínez-Magaña; Blanca Estela Pérez-Aldana; Alberto Ortega-Vázquez; Alma Delia Genis-Mendoza; David José Dávila-Ortiz de Montellano; Ernesto Soto-Reyes; Humberto Nicolini; Marisol López-López; Nancy Monroy-Jaramillo
Journal:  Pharmaceuticals (Basel)       Date:  2021-02-04

Review 6.  Drug Repurposing for Triple-Negative Breast Cancer.

Authors:  Marta Ávalos-Moreno; Araceli López-Tejada; Jose L Blaya-Cánovas; Francisca E Cara-Lupiañez; Adrián González-González; Jose A Lorente; Pedro Sánchez-Rovira; Sergio Granados-Principal
Journal:  J Pers Med       Date:  2020-10-29

7.  SAveRUNNER: an R-based tool for drug repurposing.

Authors:  Giulia Fiscon; Paola Paci
Journal:  BMC Bioinformatics       Date:  2021-03-23       Impact factor: 3.169

8.  Target Discovery for Host-Directed Antiviral Therapies: Application of Proteomics Approaches.

Authors:  Merve Cakir; Kirsten Obernier; Antoine Forget; Nevan J Krogan
Journal:  mSystems       Date:  2021-09-14       Impact factor: 6.496

9.  RepCOOL: computational drug repositioning via integrating heterogeneous biological networks.

Authors:  Ghazale Fahimian; Javad Zahiri; Seyed Shahriar Arab; Reza H Sajedi
Journal:  J Transl Med       Date:  2020-10-02       Impact factor: 5.531

10.  Drug Repositioning and Subgroup Discovery for Precision Medicine Implementation in Triple Negative Breast Cancer.

Authors:  Zainab Al-Taie; Mark Hannink; Jonathan Mitchem; Christos Papageorgiou; Chi-Ren Shyu
Journal:  Cancers (Basel)       Date:  2021-12-14       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.